Cookie use on MRCVSonline
We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive all cookies.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Bova UK confirms omeprazole ‘free from testosterone’
“Many vets and horse owners now rely on long acting injectable omeprazole for horses that do not respond to oral treatment.”

New batch tested following concerns from the racing industry

Drug company Bova UK has confirmed its long-acting injectable omeprazole has been declared free from testosterone, after low levels were found in the product last month.

Supply of the product ceased in Australia after the initial discovery by the New South Wales racing authority.

Samples tested by the British Horseracing Authority (BHA) confirmed the issue extended to the UK and the racing body recently advised against using injectible omeprazole in racehorses.

Testing by the Australian Racing Forensic Laboratory (ARFL) did not detect testosterone in the newly prepared batch of Bova’s 100mg/ml injectable omeprazole formulation.

Racing New South Wales released a statement to confirm that the product can continue to be used in racehorses following the guidance of Australian Commonwealth and State legislation.

Nick Bova, the firm’s managing director, said: “Traces of testosterone in the previous batch were less than one millionth of the internationally accepted standard for impurities. Independent experts confirmed that there could be no adverse effects on equine health or equestrian sport, however, we have taken steps to identify and completely eliminate the excipient ingredient that contained traces of testosterone.

“Bova can confirm that new batches of this product will not contain the previous trace levels of testosterone and therefore Bova are confident there will be no antidoping issues, no matter what the equestrian pursuit is.”

He added: “Many vets and horse owners now rely on long acting injectable omeprazole for horses that do not respond to oral treatment.”

Following the news, the BHA issued an updated statement on the use of the product: “The BHA are aware of the most recent results from the batch analysed in Australia. Anyone treating thoroughbreds from birth to retirement from racing should consider the latest information, alongside that from analysis of previous batches, in deciding whether to use the product.”

 

Become a member or log in to add this story to your CPD history

COVID-19 resources for veterinary professionals

News Story 1
 RCVS Knowledge, the charity partner of the Royal College of Veterinary Surgeons (RCVS), has published a page of COVID-19 coronavirus resources for veterinary professionals across the industry.

The resource, which can be found here, includes veterinary advice, updates, research and evidence regarding the virus. The advice encompasses information to help veterinary professionals respond to questions from their clients and the BCVA's latest guidance for farm animal vets.

Veterinary professionals are urged to share the resource on social media and let RCVS Knowledge know of any additions. 

Click here for more...
News Shorts
BVA senior vice president appointed chair of FVE working group

Senior vice president of the BVA Dr Simon Doherty has been appointed as chair of the Food Safety & Sustainability working group of the Federation of Veterinarians in Europe (FVE).

Dr Doherty has 20 years' experience in farm animal and equine veterinary practice, industry and academia. He has been working as a senior lecturer at the Queen's University Belfast Institute for Global Food Security since 2018 and is a trustee of Send a Cow and the Animal Welfare Foundation.

The Food Safety & Sustainability working group will support FVE in all matters related to food safety, food security and sustainable livestock systems. It will also assist FVE in taking the most effective policies at EU level.